UnitedHealth Group Incorporated FY2023 income statement | sankey.it

UNHFY2023

UnitedHealth Group Incorporated

USD, fiscal year ended 2023-12-31

Operating Expenses: R&D 0% | SG&A 0% of revenue

Revenue

$371.6B+15%

Gross margin

24.5%-0.1 pts

Operating margin

8.7%-0.1 pts

Net margin

6.0%-0.2 pts

Open full screen

Revenue segments

No segment breakdown available for this filing - the flow shows revenue narrowing straight into cost and profit.

Period history

Revenue, by year

Income statement

Line	FY2023	YoY
Revenue	$371,622,000,000	+15%
Cost of revenue	$280,664,000,000	+15%
Gross profit	$90,958,000,000	+14%
Operating expenses	$58,600,000,000	+14%
Operating income	$32,358,000,000	+14%
Other income/expense, net	-$3,246,000,000	-55%
Income before tax

More in Healthcare

LLY+48%Q2 FY2026

Eli Lilly and Company

Fiscal period end: December 31, 2023
Source: Financial Modeling Prep, via the DATA project
Diagram generated: September 3, 2026